anmelden
FTSE All-Share
5.504,53
PKT
-21,74
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | BP Verkaufen | DZ BANK | |
| 11.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | BP Sector Perform | RBC Capital Markets | |
| 11.02.25 | BP Buy | Jefferies & Company Inc. | |
| 11.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 11.02.25 | BP Buy | UBS AG | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 11.02.25 | Glencore Outperform | RBC Capital Markets | |
| 11.02.25 | Diageo Sector Perform | RBC Capital Markets | |
| 10.02.25 | BAT Buy | UBS AG | |
| 10.02.25 | GSK Hold | Deutsche Bank AG | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 10.02.25 | Unilever Sell | UBS AG | |
| 10.02.25 | BP Sector Perform | RBC Capital Markets | |
| 10.02.25 | Rio Tinto Neutral | UBS AG | |
| 10.02.25 | BP Buy | Jefferies & Company Inc. | |
| 10.02.25 | BP Buy | Jefferies & Company Inc. | |
| 07.02.25 | AstraZeneca Halten | DZ BANK | |
| 07.02.25 | BP Sector Perform | RBC Capital Markets | |
| 07.02.25 | GSK Outperform | Bernstein Research | |
| 07.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 06.02.25 | GSK Hold | Deutsche Bank AG | |
| 06.02.25 | AstraZeneca Neutral | UBS AG | |
| 06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 06.02.25 | BAT Buy | UBS AG | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Rio Tinto Neutral | UBS AG | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | Diageo Outperform | Bernstein Research | |
| 05.02.25 | Diageo Sell | Deutsche Bank AG | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | BAT Neutral | Goldman Sachs Group Inc. |